Mobile Menu

Search Results

Search results for: Health

Enabling Precision medicine for everyone: New pharmacogenomics solution launched in the US

The PGx program is an industry-first solution that will protect patients from being prescribed ineffective or harmful drugs.

“We need to have resilience and tolerance for failure” – Interview with Guillermo Del Angel, Alexion Pharmaceuticals

FLG: Can you introduce yourself and your work? I’m Guillermo del Angel and I’m the Senior Director for Data Science […]

New diagnostic for Coronavirus receives CE mark

Yesterday, a test developed by Co-diagnostics for the detection of SARS-CoV-2, received CE marking as the virus nears “pandemic” status. CE-IVD marking indicates that the IVD conforms with relevant EU directives regarding the health and safety of the product.

Alzheimer’s disease genetic research consortium launched in New York

The State University of New York (SUNY) is running the program with $20 million funding from the Empire State Development’s […]

FDA releases list of evidence-based pharmacogenetic variants

Pharmacogenetics (PGx) is the study of how an individual’s genetic makeup affects their drug response and metabolism. An understanding of PGx could help clinicians make prescribing decisions and has the potential to be implemented in routine care worldwide. PGx has understandably been gaining traction and support, with pharmacogenomic elements being implemented into many international Genomic studies.

WGS – The future of consumer genomics

With the falling cost of genome sequencing, it comes as no surprise that there is a growing interest in expanding the availability and accessibility of genomics via consumer testing. Now, Nebula Genomics has entered the market by launching a comprehensive at-home test that analyses the whole genome for just $299.

WhopperPhage – The huge virus with CRISPR components

Huge viruses with CRISPR-Cas and translational components have been described by researchers at the University of California, Berkeley – providing […]

“We are all billionaires in terms of our genome data” – Interview with Prof. Ernst Hafen, Professor of Systems Genetics, ETH Zurich

Professor Ernst Hafen is based at the Institute of Molecular Systems Biology at ETH Zurich. He studied the developmental and […]

Machine learning identifies epigenetic markers of Schizophrenia

We know from twin studies that Schizophrenia carries a 80% heritability risk, but haven’t yet managed to deduce exact genetic […]